Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Deferred Taxes (2021 - 2025)

Nutex Health's Deferred Taxes history spans 6 years, with the latest figure at -$5.9 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 48.5% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached $17.1 million, up 230.02%, while the annual FY2025 figure was $17.1 million, 230.02% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$5.9 million at Nutex Health, down from $27.8 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $27.8 million in Q3 2025 and bottomed at -$11.4 million in Q4 2024.
  • The 5-year median for Deferred Taxes is -$984810.0 (2021), against an average of -$651089.9.
  • The largest YoY upside for Deferred Taxes was 4550.0% in 2025 against a maximum downside of 2531.58% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$984810.0 in 2021, then soared by 264.61% to $1.6 million in 2022, then tumbled by 324.44% to -$3.6 million in 2023, then tumbled by 213.04% to -$11.4 million in 2024, then skyrocketed by 48.5% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Deferred Taxes are -$5.9 million (Q4 2025), $27.8 million (Q3 2025), and -$2.4 million (Q2 2025).